Research news

Partners agree to share resources, establish steering committee for closer collaboration

On April 20, 2018, Canadian, Chinese and Cuban neuroscience institutes strengthened an existing partnership with the signing of a memorandum of understanding in Chengdu, China.

Partners in the agreement include The Montreal Neurological Institute and Hospital (The Neuro) of McGill University, The Cuban Neuroscience Center, The University of Electronic Sciences and Technology of China, The West China Hospital, and The Tianfu New Area of Chengdu (TFNA).

Classified as: Canada, China, Cuba, dementia, Alzheimer's disease, Research, Partnership
Published on: 23 Apr 2018

The institute that developed the “Montreal Procedure” continues to be on the cutting edge

The Neuro is recognized worldwide as a leader in epilepsy research and treatment. From the beginning, Neuro founder, Dr. Wilder Penfield, made epilepsy a central focus. He and his colleagues developed a surgical treatment for epilepsy patients known as the “Montreal Procedure,” which today is in use throughout the world. The Neuro became a pioneer in studying epilepsy through the use of electroencephalography (EEG) and magnetic resonance imaging (MRI).

Classified as: epilepsy, Montreal Neurological Institute & Hospital, Wilder Penfield Lecture
Published on: 26 Mar 2018

2017 Québec Science Discovery of the Year Award goes to the cancer-detection probe developed by Kevin Petrecca and Frédéric Leblond

Québec Science magazine’s 25-year tradition continues: every fall, a jury comprised of researchers and journalists selects the top 10 most impressive discoveries in Quebec in the past year and the public is asked to vote to select the winner. This year, a cancer-detection probe was chosen by nearly a third of approximately 4,400 votes cast in the 2017 Discovery of the Year contest.

Classified as: Kevin Petrecca, Frederic Leblond, cancer probe, ramen spectroscopy, Quebec Science, brain cancer, brain tumour
Published on: 19 Mar 2018

Congratulations to Assistant Professor Dr. Huy Bui, who has been named a 2017 CIFAR Azrieli Global Scholar!

Published on: 9 Mar 2018

Collaboration between departmental members Drs. D. Reinhardt and P. Campeau has received new 5-year funding from the Canadian Institutes of Health Research for the grant entitled “Role of fibronectin mutations in spondylometaphyseal dysplasia and idiopathic scoliosis” in the amount of $680,850. Congratulations!

 

 

Published on: 9 Mar 2018

Industry and academia to share expertise in effort to develop improved methods to produce and characterize antibodies and reagents for neurological research

Classified as: Thermo Fisher, open science, ALS, Parkinson's disease, ataxia, reagrents
Published on: 5 Mar 2018

Canadian Open Neuroscience Platform will make disseminating and publishing data easier

Modern neuroscience research can produce massive amounts of data, which researchers can use to find patterns revealing anything from the first physiological signs of Alzheimer’s disease to a new drug target that could stop neurodegeneration. However, this data must be stored, processed, and distributed effectively.

Classified as: neuroinformatics, Alan Evans, CONP, Canadian Open Neuroscience Platform, Brain Canada
Published on: 19 Feb 2018

Volume in brain region linked to physiological changes characteristic of AD

New research has drawn a link between changes in the brain’s anatomy and biomarkers that are known to appear at the earliest stages of Alzheimer’s disease (AD), findings that could one day provide a sensitive but non-invasive test for AD before cognitive symptoms appear.

Classified as: Alzheimer's disease, AD, MRI, Christine Tardif, Mallar Chakravarty, Douglas Institute
Published on: 19 Dec 2017

Industry and academia team up for the benefit of people suffering from ALS

A unique industry-academia partnership will increase the rate at which promising drug compounds can be tested as potential treatments for amyotrophic lateral sclerosis (ALS), a disease with no known cure that affects 200,000 people worldwide.

The partnership between The Montreal Neurological Institute and Hospital (MNI) and Takeda Pharmaceutical Company Limited (Takeda) will allow compounds developed by Takeda scientists to be tested on cell lines produced at the MNI.

Classified as: Takeda, stem cells, ALS, hiPSCs, amyotrophic lateral sclerosis, open science, C-BIGR, Open Drug Discovery Platform
Published on: 4 Dec 2017

Grants for Heather Durham, Stefano Stifani and Jay Ross total just over $2 million 

Three MNI researchers have received grants from the ALS Society of Canada worth a total of more than $2 million.  

Published on: 24 Nov 2017

Brain stimulation can change how much we enjoy and value music

Enjoyment of music is considered a subjective experience; what one person finds gratifying, another may find irritating. Music theorists have long emphasized that although musical taste is relative, our enjoyment of music, be it classical or heavy metal, arises, among other aspects, from structural features of music, such as chord or rhythm patterns that generate anticipation and expectancy.

Classified as: music, Robert Zatorre, Ernest Mas Herrero, fronto-striatal circuits, TMS, transcranial magnetic stimulation
Published on: 20 Nov 2017

Researchers develop method that could one day be used in brain trauma lawsuits

 

Lawyers representing both sides in concussion lawsuits against sports leagues may eventually have a new tool at their disposal: a diagnostic signature that uses artificial intelligence to detect brain trauma years after it has occurred. 

Classified as: Concussion, Athletics, Sports, hockey, football, Sébastien Tremblay, Ludmer Centre, MRI
Published on: 12 Jul 2017

Deep learning transforming neuroscience research

In an article published in Nature on Feb. 15, 2017, researchers, including principal investigators from the Montreal Neurological Institute’s McConnell Brain Imaging Centre (BIC), used magnetic resonance imaging (MRI) to predict the development of autism in babies.

Classified as: MNI, autism, Neuro, Sylvain Baillet, BIC, neuroimaging, brain imaging centre, deep learning
Published on: 20 Mar 2017

Once again the Cystic Fibrosis Translational Research Centre (CFTRc) team from McGill University participated in the annual Walk to Make Cystic Fibrosis History. As a nation, Canada raised $3 million dollars and counting for Cystic Fibrosis research and care. 

Classified as: Research, cystic fibrosis, Fundraiser, Team, Cystic Fibrosis Translational Research Centre
Category:
Published on: 31 May 2016

For McGill scientists specializing in protein-traffi cking diseases such as cystic fi brosis (CF), October 17, 2011 marked a monumental event with the opening of McGill’s Cystic Fibrosis Translational Research Centre (CFTRc) in the McIntyre Medical Sciences Building. Celebrated by a one-day symposium highlighting McGill’s proven strengths in this research area, the Centre brings society one step closer to eradicating CF. 

 

Read the whole article HERE.

Classified as: Research, cystic fibrosis, physiology, presentation, talk, Cystic Fibrosis Translational Research Centre
Category:
Published on: 27 May 2016

Pages